This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Innovations of Jinfu Xie in Vaccine Development
Introduction
Jinfu Xie is a notable inventor based in Haverford, PA, who has made significant contributions to the field of vaccine development. His work primarily focuses on creating innovative solutions to combat infections caused by clostridium difficile. With a strong background in biotechnology, Xie has dedicated his career to advancing medical science through his inventions.
Latest Patents
Jinfu Xie holds a patent for "Vaccines against clostridium difficile comprising recombinant toxins." This invention relates to recombinant toxin A (TcdA) and toxin B (TcdB), as well as binary toxin A (CDTa) proteins that have been specifically mutated to reduce or eliminate toxicity. The patent also covers vaccines and immunogenic compositions that utilize these recombinant toxins, providing protection against infections. Furthermore, the invention includes methods for inducing an immune response by administering these vaccines to patients. Notably, the recombinant toxins are expressed in a baculovirus/insect cell expression system, showcasing Xie's innovative approach to vaccine development.
Career Highlights
Throughout his career, Jinfu Xie has been associated with Merck Sharp & Dohme Corp., a leading pharmaceutical company. His work at Merck has allowed him to collaborate with other experts in the field and contribute to groundbreaking research in vaccine technology. Xie's dedication to his work is evident in his successful patent, which addresses a critical health issue.
Collaborations
Jinfu Xie has worked alongside esteemed colleagues such as Jon Henry Heinrichs and Jean-Luc Bodmer. These collaborations have further enriched his research and development efforts, leading to advancements in the field of immunology.
Conclusion
Jinfu Xie's innovative contributions to vaccine development, particularly in combating clostridium difficile, highlight his importance in the field of biotechnology. His patent reflects a commitment to improving public health through scientific research and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile